Background: This study was designed to test the hypothesis that a combined femoral and politeal sciatic nerve blocks (FPSNB) would have excellent clinical properties and better patient satisfaction than epidural anesthesia for the great saphenous veins stripping (GSVS) surgery with multiple stab avulsion (MSA).
INTRODUCTION
Great saphenous veins stripping (GSVS) surgery with multiple stab avulsion (MSA) of varicosity is a common procedure typically performed for the varicose veins of lower extremity.
For these patients, various types of anesthesia-including local anesthesia, 1) nerve blocks, 2, 3) neuraxial blockade, 3) and general anesthesia-have been used. Among them, peripheral nerve blocks have been demonstrated to be associated with lower morbidity and a reduction in the side effects seen in the cardiovascular system caused by neuraxial or general anesthesia. 4, 5) Several reports indicate that the combination of peripheral nerve blocks with femoral and sciatic nerve provides similarly effective anesthesia and increases patient satisfaction as compared to neuraxial anesthesia. 6, 7) However, it has not been demonstrated whether the combination of femoral and sciatic nerve blocks would provide sufficient analgesia for the patient undergoing GSVS surgery with MSA. A femoral nerve block provides analgesia to medial thigh and posteromedial aspect of calf. When MSA is performed at the posterolateral aspect of calf, femoral nerve blocks can not produce sufficient analgesia because this area is innervated by a branch of sciatic nerve.
Therefore, it is reasonable to hypothesize that a combined femoral and popliteal sciatic nerve blocks (FPSNB) could provide sufficient analgesia for all procedure of vein surgery at the proximal leg and posterior part of calf. The current study was designed to test the hypothesis that a combined FPSNB would have excellent clinical properties and produce better patient satisfaction compared with epidural anesthesia for GSVS surgery with MSA.
MATERIALS AND METHODS
With Ethical Committee approval and written informed consent, 60 ASA physical status I and II inpatients, aged 24−65 year who were scheduled for elective GSVS surgery with MSA were studied. Exclusion criteria were neurological diseases, coagulation disturbances, patients with skin infection on the injection site of anesthetics, respiratory or cardiac disease, and diabetes. After an 18-gauge IV cannula had been inserted in the forearm, all patients received IM premedication with 0.05 mg/kg midazolam 30 min before going to operating room.
All patients received lactated Ringer's solution at a rate of 1 ml/kg for 1 h before arrival in the operating room and at 5− 10 ml/kg/h during the subsequent observation period. Patients were divided into two groups. Epidural group (n = 30) received an epidural anesthesia with 15 ml of 0.75% ropivacaine for unilateral or bilateral vein surgery whereas FPSNB group (n = 30) received a combined FPSNB with 25 ml of 1.5% mepivacaine for unilateral vein surgery.
Epidural anesthesia was performed at the L3-4 interspace with a 17-gauge Tuohy needle (B. Braun, Melsungen, Germany) using the midline approach, with patients in the lateral decubitus position. The epidural space was identified using a loss-of-resistance to saline technique. A 19-gauge epidural catheter was advanced 4 cm into the epidural space with the bevel directed cephalad. Fifteen ml of 0.75% ropivacaine was infused at 2 min after injecting 2 ml for a test dose of the same solution. Sensory blockade (complete loss of sharpness in pinprick perception) was evaluated bilaterally with a short-beveled needle. The dermatome was considered blocked only if the block could be demonstrated bilaterally.
FPSNB was obtained by injecting a local anesthetic solution (1.5% mepicavaine) close to the femoral and popliteal sciatic nerves. The total dose administered was 25 ml of 1.5% mepivacaine, 15 ml of which was used for the femoral nerve block Statistical analysis was performed using SPSS version 11.0.
Differences between means of continuous variables were estimated using Students' t test. Categorical data were compared In FPSNP group, thirteen patients were received with 50−100 μg of fentanyl for the control of incisional pain on inguinal area whereas 5 patients received it at the time of incision at the postrolateral calf area. FPSNB means a combined femoral and politeal sciatic nerve block. 
RESULTS
Demographic data were comparable in both groups (Table 1) .
Anesthetic characteristics and anesthesia-related complications of both blocks are noted in Table 2 .
Time from initial injection to the start of surgery and the duration of sensory blockade were not different between groups. However, the duration of anesthesia or the duration of surgery in FPSNB group was shorter than that of epidural group (P ＜ 0.01). Anesthesia-related complication, such as shivering, hypotension, bradycardia and postoperative voiding difficulty, was high in the epidural group whereas FPSNB group had no these complications (P ＜ 0.01). Additional analgesia with fentanyl was more frequently used in FPSNB group (P ＜ 0.05) whereas there was no difference in comparison of incidence of midazolam between two groups (P ＞ 0.05). In FPSNP group, 13 patients were received with 50−100 μg of fentanyl for the control of incisional pain on inguinal area, and 5 patients received it at the time of incision at the postrolateral calf area.
Data of questionnaire study were shown in Table 3 . Patient satisfaction of FPSNB group was higher than epidural anesthesia (88.1 ± 13.2 vs 76.5 ± 15.8, FPSNB vs epidural group, P ＜ 0.01). In addition, the incidence of unpleasant feeling during anesthetic procedure in FPSNB group was less than epidural anesthesia (26.7% vs 56.7%, P ＜ 0.05). Moreover, the incidence of pain on needle entry site was comparable;
66.7% of patient in epidural group had a back pain whereas 16 .7% of patient in FPSNB group had a pain on inguinal area or popliteal area. However, the incidence of incisional pain at 
DISCUSSION
This study shows that a combined FPSNB with 1.5% of mepivacaine, with a small amount of narcotics, has similar anesthetic characteristics (onset and duration of action), fewer anesthesia-related complications and superior patient satisfaction as compared with epidural anesthesia with 0.75% of ropivacaine for the patient undergoing elective GSVS surgery with MSA. These results suggest that a combined FPSNB is an adequate anesthetic technique for unilateral varicose veins surgery in lower extremity.
Since femoral nerve block results in anesthesia in the anteromedial thigh and medial aspect of the lower leg, a popliteal sciatic nerve block in the current study was performed to provide analgesia to posterolateral aspect of the lower leg. Vloka et al 3) reported that femoral nerve block with genitofemoral nerve infiltration provides sufficient analgesia and superior recovery characteristics to neuraxial anesthesia for the GSVS surgery. However, it was not clear in their study whether MSA or any procedure was performed at the lower leg. In contrast, current study shows that a combined FPSNB can provide adequate analgesia for the GSVS surgery at the proximal legs and MSA at the calf. We believe that the addition of a popliteal sciatic nerve block to femoral nerve block gives surgeon additional benefit of avoiding multiple injections of local anesthetics at the calf.
As routine in our department we use 0.75% of ropivacaine for epidural anesthesia for the patients with elective non-ambulatory GSVS surgery with MSA. Fanelli et al 8) described that 0.75% of ropivacaine for combined sciatic and femoral nerve blocks had a prolonged duration of motor blocks and sensory analgesia (around 10−11 h) whereas 2% of mepivacaine had intermediate duration (around 5−6 h). To avoid the long duration of sensory analgesia with 0.75% of ropivacaine, we used 1.5% of mepivacaine for a combined FPSNB in this study.
The concentration and volume of local anesthetic administered is one of the major determinants for the success of a regional block procedure. Cappelleri et al 9) reported that the minimum effective anesthetic concentration of mepivacaine with 30 ml resulting in complete block of the femoral nerve in 50% of cases was 1.06 ± 0.31%. Casati et al 10) reported that the minimum local anesthetic volume providing successful femoral nerve block in 50% of cases was 14 ± 2 ml in the ropivacaine group and 15 ± 2 ml in the bupivacaine group. Based on these reports, we thought that 15 ml of 1.5% mepivacaine in current study was a minimum effective anesthetic dose for femoral nerve block. Although 15 ml of 1.5% mepivacaine was not fully enough for the complete "three-in-one" femoral nerve block, we had to adjust an anesthetic dose for the femoral nerve block because of a popliteal sciatic nerve block. A maximal recommended dose of plain mepivacaine without epinephrine for single perineural injection has been reported with a 400 mg. 11) Therefore, we divided a maximal recommended dose into two doses; 15 ml of 1.5% mepivacaine for the formal nerve block and 10 ml of 1.5% mepivacaine for the popliteal sciatic nerve block. In addition, we also considered the use of a small an anesthetic dose for each nerve block because a long lasting block can occur even after administration of low dose local anesthetics and the blocking leg can give way even 10−18 h after the injection. 12) However, it was easy to anticipate that FPSNB group was needed a more analgesic supplementation with fentanyl because the use of an insufficient dose for each block was not avoidable.
Thirteen patients in FPSNB group were received an additional analgesia with 50−100 μg of IV fentanyl for the control of an incisional pain on inguinal area. We thought that a pain on incision at the inguinal area might be caused by the sparing of genitofemoral nerve. Vloka et al 3) described that a pain on incision at the inguinal area was caused by an absence of block of genitofemoral nerve instead of an incomplete block of the femoral nerve. They suggested that genitofemoral nerve infiltration had a role of supplemental analgesia to femoral nerve block. In current study, we did not perform the genitofemoral nerve infiltration. Instead of it, we added the 5 ml of 1% lidocaine infiltration into the incisional area subcutaneously by a surgeon when a patient had a pain on incisional area and injected 50−100 μg of IV fentanyl as supplemental analgesia. It should be noted that patient satisfaction of FPSNB group was higher than epidural anesthesia. Taken all into consideration, our results suggest that a pain on incision at the inguinal area in the FPSNB group might be a minor contributing factor in the aspects of patient satisfaction for a combined FPSNB.
In the current study, five patients in the FPSNB group were needed additional analgesia with 50−100 μg of IV fentanyl for the control of incisional pain during the MSA at the postrolateral calf. It might be caused by the incomplete block of politeal sciatic nerve because of use of a small dose for the popliteal sciatic nerve block. Taboada et al 13) reported that the minimum effective volume of local anesthetic required to block the sciatic nerve with 1.5% mepivacaine was 12 ± 3 ml at the subgluteal area and 20 ± 3 ml at the popliteal area. They suggested that the effective dose 95% for adequate block of the sciatic nerve was 30 ml at the popliteal area. As mentioned above, we thought that the use of 10 ml of 1.5% mepivacaine for the popliteal sciatic nerve block in the current study was an unavoidable methodological limitation by considering a maximal recommended dose of mepivacaine for perineural injection. However, several reports 14, 15) indicate that ana- to decrease the level of patient satisfaction in the epidural group. Vloka et al 3) also reported that the incidece of back pain after spinal anesthesia was 53%. In addition, psychological factor like unpleasant feeling during needle placement also could be a contributing factor to decrease the patient satisfaction in epidural group.
Although the current study is not ambulatory operationbased, our results suggest that FPSNB with 1.5% of mepivacaine is also adequate anesthetic choice for ambulatory-based unilateral GSVS surgery with MSA because FPSNB has inter-mediate duration of analgesia and immediate postoperative analgesia without adverse events such as urinary retention.
Moreover, FPSNB had earlier home discharge than epidural anesthesia. However, it should be carefully considered because patient discharge after ambulatory surgery is known to be influenced by various factors not directly related to the anesthetic procedure such as surgical severity, postoperative surgical complication or family members to accompany the home.
The protocol for the present study would have been more robust had it been possible for the duration of anesthesia and surgery to be identical between the two groups. These differences may be derived from the bilateral GSVS surgery in the epidural group. Although the longer duration of anesthesia or surgery in the epidural group as compared with FPSNB group could be a bias in analysis of our results, these differences between two groups play a minor role on patient satisfaction for the anesthetic procedure by itself. We believe that sustained back pain after postoperative several days or an unpleasant feeling during the anesthetic procedure, which is the reason of lower patient satisfaction in the epidural group, is not related with the duration of anesthesia or surgery.
In summary, this study demonstrates that, in patients scheduled to have elective GSVS surgery with MSA, the use of a combined FPSNB performed with 1.5% mepivacaine with supplemental narcotics results in a similar time to readiness of surgery and an effective anesthesia, lower adverse events and superior patient satisfaction as compared to epidural anesthesia with 0.75% ropivacaine. We suggest that a combined FPSNB is an adequate anesthetic technique for unilateral GSVS surgery with MSA.
